CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 28 enrolled
Drug / intervention
erythromycin lactobionate +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02633579
NCT02633579N/ACompleted
CompareCT.gov

The Role of Induced Phase 3 Contractions in the Control of Hunger and Food Intake

Universitaire Ziekenhuizen KU Leuven·interventional·Posted Dec 17, 2015·Updated Dec 17, 2015

In Brief

A clinical study evaluating erythromycin lactobionate, Atropine, and 2 other interventions for Healthy. Completed, enrolled 28 participants.

Detailed Summary

In this study, the investigators will evaluate if the food intake associated with the infusion of erythromycin is caused by the phase 3 contractions or by another yet unknown effect of erythromycin. To obtain this the investigators will use atropine, a muscarinic receptor antagonist, to inhibit the formation of contractions induced by a low dose of erythromycin

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
Countries--
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedDec 17, 2015
Enrollment StartOct 1, 2012
Primary CompletionAug 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 10.5 years ago

Interventions

erythromycin lactobionatedrug

intravenous administration of erythromycin

Atropinedrug

intravenous administration of atropine

Erythromycin with atropinedrug

intravenous administration of erythromycin with saline

Salinedrug

intravenous administration of saline